iCAD (ICAD) 10-K29 Mar 242023 FY Annual reportFinancial data

Company Profile

Document And Entity Information

Document And Entity Information - USD ($)	12 Months Ended
Document And Entity Information - USD ($)	Dec. 31, 2023	Mar. 22, 2024	Jun. 30, 2023
Document Information [Line Items]
Entity Central Index Key	0000749660
Entity Registrant Name	iCAD INC
Amendment Flag	false
Current Fiscal Year End Date	--12-31
Document Fiscal Period Focus	FY
Document Fiscal Year Focus	2023
Document Type	10-K
Document Annual Report	true
Document Period End Date	Dec. 31, 2023
Document Transition Report	false
Entity File Number	001-09341
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	02-0377419
Entity Address, Address Line One	98 Spit Brook Road, Suite 100
Entity Address, City or Town	Nashua
Entity Address, State or Province	NH
Entity Address, Postal Zip Code	03062
City Area Code	603
Local Phone Number	882-5200
Title of 12(b) Security	Common Stock, $0.01 par value
Trading Symbol	ICAD
Security Exchange Name	NASDAQ
Entity Well-known Seasoned Issuer	No
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	false
ICFR Auditor Attestation Flag	false
Document Financial Statement Error Correction [Flag]	false
Entity Shell Company	false
Entity Public Float			$ 38,675,432
Entity Common Stock, Shares Outstanding		26,540,030
Auditor Name	BDO USA, P.C.
Auditor Location	Boston, Massachusetts
Auditor Firm ID	243

Consolidated Balance Sheets

Consolidated Balance Sheets - USD ($)	Dec. 31, 2023	Dec. 31, 2022
Current assets:
Cash and cash equivalents	$ 21,670,000	$ 21,313,000
Trade accounts receivable, net of allowance for credit losses of $277 in 2023 and $100 in 2022	6,392,000	5,769,000
Inventory, net	917,000	2,054,000
Prepaid expenses and other current assets	699,000	1,571,000
Current assets held for sale	0	7,534,000
Total current assets	29,678,000	38,241,000
Property and equipment:
Internal-use software	1,172,000	0
Equipment	1,482,000	1,421,000
Leasehold improvements	110,000	110,000
Furniture and fixtures and other	104,000	23,000
Property and equipment	2,868,000	1,554,000
Less accumulated depreciation and amortization	1,045,000	850,000
Property and equipment, net	1,823,000	704,000
Other assets:
Operating lease assets	461,000	670,000
Other assets	849,000	19,000
Intangible assets, net of accumulated amortization of $8,488 in 2023 and $8,372 in 2022	148,000	264,000
Goodwill	8,362,000	8,362,000
Deferred tax assets	97,000	116,000
Noncurrent assets held for sale	0	3,329,000
Total assets	41,418,000	51,705,000
Current liabilities:
Accounts payable	712,000	1,446,000
Accrued and other expenses	2,448,000	2,541,000
Lease payable, current	188,000	217,000
Deferred revenue, current	3,400,000	3,653,000
Current liabilities held for sale	0	5,595,000
Total current liabilities	6,748,000	13,452,000
Lease payable, long-term	273,000	455,000
Deferred revenue, long-term	974,000	393,000
Deferred tax	6,000	6,000
Noncurrent liabilities held for sale	0	2,497,000
Total liabilities	8,001,000	16,803,000
Commitments and contingencies (Note 16)
Stockholders’ equity:
Preferred stock, $ .01 par value: authorized 1,000,000 shares; none issued.	0	0
Common stock, $ .01 par value: authorized 60,000,000 shares; issued 26,540,030 in 2023 and 25,446,407 in 2022. Outstanding 26,354,199 in 2023 and 25,260,576 in 2022	265,000	254,000
Additional paid-in capital	306,250,000	302,899,000
Accumulated deficit	(271,683,000)	(266,836,000)
Treasury stock at cost, 185,831 shares in 2023 and 2022	(1,415,000)	(1,415,000)
Total stockholders’ equity	33,417,000	34,902,000
Total liabilities and stockholders’ equity	$ 41,418,000	$ 51,705,000

Consolidated Balance Sheets (Pa

Consolidated Balance Sheets (Parentheticals) - USD ($) $ in Thousands	Dec. 31, 2023	Dec. 31, 2022
Allowance for doubtful accounts on trade accounts receivable	$ 277	$ 100
Intangible assets, accumulated amortization	$ 8,488	$ 8,372
Preferred stock, par value (in dollars per share)	$ 0.01	$ 0.01
Preferred stock, shares authorized (in shares)	1,000,000	1,000,000
Preferred stock, shares issued (in shares)	0	0
Common stock, par value (in dollars per share)	$ 0.01	$ 0.01
Common stock, shares authorized (in shares)	60,000,000	60,000,000
Common stock, shares issued (in shares)	26,540,030	25,446,407
Common stock, shares outstanding (in shares)	26,354,199	25,260,576
Treasury Stock, Common, Shares (in shares)	185,831	185,831

Consolidated Statements of Oper

Consolidated Statements of Operations - USD ($) shares in Thousands, $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Revenue:
Revenue	$ 17,318	$ 19,802
Cost of Revenue:
Cost of revenue	2,533	2,983
Gross profit	14,785	16,819
Operating expenses:
Engineering and product development	5,161	5,493
Marketing and sales	7,740	10,790
General and administrative	9,324	10,517
Amortization and depreciation	249	217
Total operating expenses	22,474	27,017
Loss from operations	(7,689)	(10,198)
Other income (expense)
Interest expense	(16)	(10)
Interest income	729	213
Other	(14)	(39)
Other income, net	699	164
Loss before income tax expense	(6,990)	(10,034)
Benefit (provision) for income taxes	(20)	116
Loss from continuing operations	(7,010)	(9,918)
Income (loss) from discontinued operations	2,163	(3,738)
Net loss and comprehensive loss	$ (4,847)	$ (13,656)
Net loss per share:
Loss from continuing operations (in dollars per share)	$ (0.27)	$ (0.39)
Income (loss) from discontinued operations (in dollars per share)	0.08	(0.15)
Net loss per share, basic and diluted (in dollars per share)	$ (0.19)	$ (0.54)
Weighted average number of shares used in computing net loss per share:
Basic shares used in the calculation of earnings per share (in shares)	25,613	25,202
Diluted (in shares)	25,613	25,202
Product [Member]
Revenue:
Revenue	$ 9,930	$ 12,620
Cost of Revenue:
Cost of revenue	1,387	1,658
Service [Member]
Revenue:
Revenue	7,388	7,182
Cost of Revenue:
Cost of revenue	1,060	1,217
Amortization and Depreciation [Member]
Cost of Revenue:
Cost of revenue	$ 86	$ 108

Consolidated Statements of Stoc

Consolidated Statements of Stockholders' Equity - USD ($) $ in Thousands	Common Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	Treasury Stock, Common [Member]	Total
Balance (in shares) at Dec. 31, 2021	25,326,086
Balance at Dec. 31, 2021	$ 253	$ 300,859	$ (253,180)	$ (1,415)	$ 46,517
Issuance of common stock relative to vesting of restricted stock, net of shares forfeited for tax obligations (in shares)	725
Issuance of common stock relative to vesting of restricted stock, net of shares forfeited for tax obligations	$ 0	0	0	0	$ 0
Issuance of common stock pursuant to stock option plans (in shares)	73,500				35,809
Issuance of common stock pursuant to stock option plans	$ 1	206	0	0	$ 207
Issuance of common stock pursuant to employee stock purchase plan (in shares)	46,096
Issuance of common stock pursuant to employee stock purchase plan	$ 0	148	0	0	148
Stock-based compensation	0	1,686	0	0	1,686
Net loss	$ 0	0	(13,656)	0	(13,656)
Balance (in shares) at Dec. 31, 2022	25,446,407
Balance at Dec. 31, 2022	$ 254	302,899	(266,836)	(1,415)	34,902
Issuance of common stock pursuant to stock option plans (in shares)	35,809
Issuance of common stock pursuant to stock option plans	$ 0	80	0	0	80
Stock-based compensation	0	1,316	0	0	1,316
Net loss	$ 0	0	(4,847)	0	(4,847)
Issuance of common stock, net of issuance costs of $338 (in shares)	1,057,814
Issuance of common stock, net of issuance costs of $338	$ 11	1,955	0	0	1,966
Balance (in shares) at Dec. 31, 2023	26,540,030
Balance at Dec. 31, 2023	$ 265	$ 306,250	$ (271,683)	$ (1,415)	$ 33,417

Consolidated Statements of St_2

Consolidated Statements of Stockholders' Equity (Parentheticals) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Shares forfeited for tax obligations (in shares)		150
Issuance Costs	$ 338

Consolidated Statements of Cash

Consolidated Statements of Cash Flows - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Cash flow from operating activities:
Net loss	$ (4,847)	$ (13,656)
Adjustments to reconcile net loss to net cash used for operating activities:
Gain on sale of business	(2,592)	0
Amortization	170	211
Depreciation	239	310
Non-cash lease expense	462	708
Bad debt provision	177	732
Stock-based compensation expense	1,316	1,686
Deferred tax	20	(116)
Other, net	(1)	9
Changes in operating assets and liabilities, net of acquisition:
Accounts receivable	419	(739)
Inventory	1,489	(1,218)
Prepaid and other assets	840	1,152
Accounts payable	(811)	(806)
Accrued and other expenses	(1,554)	(961)
Lease liabilities	(484)	(767)
Deferred revenue	193	665
Total adjustments	(117)	866
Net cash provided by (used for) operating activities	(4,964)	(12,790)
Cash flow used for investing activities:
Proceeds from sale of business, net of transaction costs	4,539	0
Additions to patents, technology and other	0	(10)
Additions to property and equipment	(922)	(524)
Capitalization of internal-use software development costs	(342)	0
Net cash provided by (used for) investing activities	3,275	(534)
Cash flow from financing activities:
Issuance of common stock for cash, net	1,966	0
Issuance of common stock pursuant to Employee Stock Purchase Plan	0	148
Issuance of common stock pursuant to stock option plans	80	207
Net cash provided by financing activities	2,046	355
Increase (decrease) in cash and cash equivalents	357	(12,969)
Cash and cash equivalents, beginning of year	21,313	34,282
Cash and cash equivalents, end of year	21,670	21,313
Supplemental disclosure of cash flow information:
Interest paid	16	9
Taxes paid	0	0
Right-of-use assets obtained in exchange for new operating lease liabilities	$ 0	$ 3,011

Insider Trading Arrangements

Insider Trading Arrangements	12 Months Ended
Insider Trading Arrangements	Dec. 31, 2023
Insider Trading Arr Line Items
Material Terms of Trading Arrangement [Text Block]	9B. Other Information. Not
Rule 10b5-1 Arrangement Adopted [Flag]	false
Non-Rule 10b5-1 Arrangement Adopted [Flag]	false
Rule 10b5-1 Arrangement Terminated [Flag]	false
Non-Rule 10b5-1 Arrangement Terminated [Flag]	false

Note 1 - Organization and Busin

Note 1 - Organization and Business	12 Months Ended
Note 1 - Organization and Business	Dec. 31, 2023
Notes to Financial Statements
Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]	Note 1 Organization and Business Unless otherwise noted, all amounts presented in these Notes to the Consolidated Financial Statements are in thousands of dollars. iCAD, Inc. and subsidiaries (the “Company” or “iCAD”) is a global medical technology company providing innovative cancer detection solutions. As discussed in Note 2, October 2023. one 15 The Company maintains its headquarters and a separate manufacturing facility in Nashua, New Hampshire and an office in Lyon, France.

Note 2 - Discontinued Operation

Note 2 - Discontinued Operations	12 Months Ended
Note 2 - Discontinued Operations	Dec. 31, 2023
Notes to Financial Statements
Disposal Groups, Including Discontinued Operations, Disclosure [Text Block]	Note 2 Discontinued Operations On October 22, 2023, November 2023 15 October 22, 2023. December 31, 2023. The closing of the Transaction occurred simultaneously with the execution of the Purchase Agreement. In connection with the Transaction, the parties entered into a transition services agreement pursuant to which the Company will provide certain migration and transition services to facilitate an orderly transition of the operation of the Business to the Buyers during the 5 The Purchase Agreement contains certain representations, warranties, covenants and indemnification provisions, including for breaches of covenants and for losses resulting from the Company’s liabilities specifically excluded from the Transaction. The Business, which had previously been presented as a separate reporting segment, meets the criteria for being reported as a discontinued operation and has been segregated from continuing operations. The following table summarizes the results from discontinued operations (in thousands): For the period ended October 22, For the year ended December 31, 2023 2022 Revenue $ 4,804 $ 8,142 Total cost of sales 2,580 5,152 Gross profit $ 2,224 $ 2,990 Total operating expenses 2,653 6,728 Pre-tax loss from operations of discontinued business (429 ) (3,738 ) Provision for income taxes — — Loss from operations of discontinued business $ (429 ) $ (3,738 ) Gain on sale of discontinued operations 2,592 — Provision for income taxes on gain on sale — — Income (loss) from discontinued operations, net of tax $ 2,163 $ (3,738 ) The following table summarizes the assets and liabilities held for sale in the Company's Consolidated Balance Sheets (in thousands): December 31, 2022 Assets Accounts receivable, net of allowance for credit losses $ 3,129 Inventories, net 3,335 Prepaid expenses and other current assets 1,070 Total current assets held for sale $ 7,534 Net property and equipment $ 370 Operating lease assets 2,691 Other assets 268 Total noncurrent assets held for sale $ 3,329 Liabilities Accounts payable $ 527 Accrued and other expenses 2,140 Lease payable - current portion 365 Deferred revenue - current portion 2,563 Total current liabilities held for sale $ 5,595 Lease payable, net of current 2,348 Deferred revenue, net of current 149 Noncurrent liabilities held for sale $ 2,497 Total operating expenses presented in the table above exclude amounts that had previously been allocated to the Business for certain shared marketing expenses. The previously allocated amounts were less than $0.1 million and $0.6 million for the years ended December 31, 2023 2022, The Business is included in the Company's Consolidated Statements of Cash Flows for the years ended December 31, 2023 2022. December 31, 2023, December 31, 2022

Note 3 - Significant Accounting

Note 3 - Significant Accounting Policies	12 Months Ended
Note 3 - Significant Accounting Policies	Dec. 31, 2023
Notes to Financial Statements
Significant Accounting Policies [Text Block]	Note 3 Significant Accounting Policies Use of Estimates The preparation of financial statements in conformity with generally accepted accounting principles in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses during the reporting period and disclosure of contingent assets and liabilities at the date of the financial statements. Actual results could differ from those estimates. It is reasonably possible that changes may Principles of Consolidation The consolidated financial statements include the accounts of the Company and its wholly owned subsidiary, iCAD France, LLC. As described in Note 2, October 2023. Risk and Uncertainty On March 12, 2020, 19 19, December 31, 2023, 19 In late February 2022, October 2023, Sustained conflict and disruption in these regions has continued through December 31, 2023 may may may not 2023, 10% Cash and cash equivalents The Company defines cash and cash equivalents as all bank accounts, money market funds, deposits and other money market instruments with original maturities of 90 may $250,000 5 not not December 31, 2023, not Financial instruments Financial instruments consist of cash and cash equivalents, trade accounts receivable, contract assets, accounts payable, accrued and other expenses and notes payable. Due to their short-term nature and market rates of interest, the carrying amounts of the financial instruments approximated fair value as of December 31, 2023 2022 Accounts Receivable and Allowance for Credit Losses Accounts receivable are customer obligations due under normal trade terms. Credit limits are initially established through a process of reviewing the financial history and stability of each customer and the Company performs continuing credit evaluations of its customers’ financial condition and generally does not December 31, 2023 2024 December 31, 2022. one three As described in Note 4, January 1, 2023 twelve December 31, 2023 2022 Inventory The Company uses the first first Property and Equipment Property and equipment are stated at cost and depreciated using the straight-line method over the estimated useful lives of the assets, which is generally three five Goodwill In accordance with FASB Accounting Standards Codification (“ASC”) Topic 350 20, “Intangibles Goodwill and Other 350 20” not Factors the Company considers important, which could trigger an impairment of Goodwill, include the following: • significant and sustained underperformance relative to historical or projected future operating results; • significant changes in the manner or use of the Company’s assets in the strategy for the Company’s overall business; • significant negative industry or economic trends; • significant and sustained decline in the Company’s stock price; and • a decline in the Company’s market capitalization below net book value. Upon the sale of its former Xoft business, the Company has one The Company performs an annual impairment assessment as of October 1 may 2023, October 1, 2023, no 2023, Fair value of the reporting unit is based on a weighting of the income approach and the market approach. For purposes of the income approach, fair value is determined based on the present value of estimated future cash flows, discounted at an appropriate risk adjusted rate. The Company uses internal forecasts to estimate future cash flows and includes estimates of long-term future growth rates based on our most recent views of the long-term forecast for each segment. Accordingly, actual results can differ from those assumed in our forecasts. Discount rates are derived from a capital asset pricing model and by analyzing published rates for industries relevant to our reporting units to estimate the cost of equity financing. The Company uses discount rates that are commensurate with the risks and uncertainty inherent in the respective businesses and in our internally developed forecasts. In the market approach, the Company uses a valuation technique in which values are derived based on market prices of publicly traded companies with similar operating characteristics and industries. A market approach allows for comparison to actual market transactions and multiples. It can be somewhat limited in its application because the population of potential comparable publicly-traded companies can be limited due to differing characteristics of the comparative business and ours, as well as the fact that market data may not may The Company corroborates the total fair values of the reporting unit using a market capitalization approach since it now operates with only one may not Long Lived Assets In accordance with FASB ASC Topic 360, 360” not ASC 360 10 35 no 360 10 35 21 may not • A significant decrease in the market price of a long-lived asset (asset group); • A significant adverse change in the extent or manner in which a long-lived asset (asset group) is being used or in its physical condition; • A significant adverse change in legal factors or in the business climate that could affect the value of a long-lived asset (asset group), including an adverse action or assessment by a regulator; • An accumulation of costs significantly in excess of the amount originally expected for the acquisition or construction of a long-lived asset (asset group); • A current period operating or cash flow loss combined with a history of operating or cash flow losses or a projection or forecast that demonstrates continuing losses associated with the use of a long-lived asset (asset group); • significant and sustained decline in the Company’s stock price. In accordance with ASC 360 10 35 17, not The Company did not December 31, 2023 December 31, 2022 Intangible assets subject to amortization consist primarily of patents, technology intangibles, trade names, customer relationships and distribution agreements purchased in the Company’s previous acquisitions. These assets are amortized on a straight-line basis or the pattern of economic benefit over their estimated useful lives of 5 to 10 years. Leases In accordance with FASB ASC Topic 842, 842" At lease inception, the Company recognizes a lease liability equal to the present value of the remaining lease payments, and a right of use asset equal to the lease liability, subject to certain adjustments, such as for lease incentives. In determining the present value of the lease payments, the Company uses its incremental borrowing rate, determined by estimating the Company’s applicable, fully collateralized borrowing rate, with adjustment as appropriate for lease term. The lease term at the lease commencement date is determined based on the non-cancellable period for which the Company has the right to use the underlying asset, together with any periods covered by an extension option if the Company is reasonably certain to exercise that option. Right-of-use assets and obligations for leases with an initial term of 12 not not third not 606, 606" ASC 842 no December 31, 2023 Certain of the Company’s leases include variable lease costs to reimburse the lessor for real estate tax and insurance expenses, and certain non-lease components that transfer a distinct service to the Company, such as common area maintenance services. The Company has elected to separate the accounting for lease components and non-lease components for real estate and equipment leases. Stock-Based Compensation The Company maintains stock-based incentive plans, under which it provides stock incentives to employees, directors and contractors. The Company grants to employees, directors and contractors, options to purchase common stock at an exercise price equal to the market value of the stock at the date of grant. The Company may not 718, “Compensation Stock Compensation 718” The Company uses the Black-Scholes option pricing model to value stock options which requires extensive use of accounting judgment and financial estimates, including estimates of the expected term participants will retain their vested stock options before exercising them, the estimated volatility of its common stock price over the expected term, and the number of options that will be forfeited prior to the completion of their vesting requirements. The Company estimates forfeitures based on historical experience with pre-vested forfeitures. To the extent actual forfeitures differ from the estimate, the difference is recorded to compensation expense in the period of the forfeiture. Fair value of restricted stock is determined based on the stock price of the underlying option on the date of the grant. Application of alternative assumptions could produce significantly different estimates of the fair value of stock-based compensation and consequently, the related amounts recognized in the Consolidated Statements of Operations. Revenue Recognition In accordance with ASC 606, may The Company applies the following five 1 Identify the contract(s) with a customer may not 2 Identify the performance obligations in the contract third not not 3 Determine the transaction price not 4 Allocate the transaction price to the performance obligations in the contract not 5 Recognize revenue when (or as) the Company satisfies a performance obligation The Company recognizes revenue from its contracts with customers primarily from the sale of products and from the sale of services. Revenue is recognized when control of the promised goods or services is transferred to a customer, in an amount that reflects the consideration the Company expects to be entitled to in exchange for those goods or services. For iCAD’s typical product revenue, control typically transfers upon shipment as title and risk of loss have passed to the customer. Services and supplies are considered to be transferred as the services are performed or over the term of the service or supply agreement. The Company enters into contracts that can include various combinations of products and services, which are generally capable of being distinct and accounted for as separate performance obligations. Perpetual software licenses are accounted for as a single performance obligation and revenue is recognized at the point in time when ownership is transferred to the customer. Taxes assessed by a governmental authority that are both imposed on and concurrent with a specific revenue-producing transaction, that are collected by the Company from a customer, are excluded from revenue. Shipping and handling costs associated with outbound freight after control of a product has transferred to a customer are accounted for as fulfillment costs and are included in cost of revenue. The Company continues to provide for estimated warranty costs on original product warranties at the time of sale. Goods and Services Classifications Products Service Contracts 12 48 Professional Services Other For all of contracts, payment terms are generally net 30 Significant Judgments The Company’s contracts with customers may may one may The Company may not Assets Recognized from the Costs to Obtain a Contract with a Customer The Company recognizes incremental costs of obtaining a contract with a customer as an asset if the Company expects the benefit of those costs to be longer than one one Right to Invoice Where applicable, the Company recognizes revenue from a contract with a customer in an amount that corresponds directly with the value to the customer of the Company’s performance completed to date and the amount to which the Company has a right to invoice. Sales and Other Similar Taxes The Company excludes sales taxes and similar taxes from the measurement of the transaction price. Significant Financing Component The Company does not one Promised Goods or Services that are Immaterial in the Context of a Contract The Company assesses materiality of promised goods or services as performance obligations in the context of a contract and the Company does not 606 The Company does not one Cost of Revenue Cost of revenue consists of the costs of products purchased for resale, cost relating to service including costs of service contracts to maintain equipment after the warranty period, inbound freight and duty, manufacturing, warehousing, material movement, inspection, scrap, rework, depreciation and in-house product warranty repairs, amortization of acquired technology and any applicable medical device tax. Warranty Costs The Company provides for the estimated cost of standard product warranty against defects in material and workmanship based on historical warranty trends, including the cost of product returns during the warranty period. Warranty costs have not Engineering and Product Development Costs and Capitalized Internal-Use Software Costs Engineering and product development costs relate to research and development efforts including Company sponsored clinical trials are expensed as incurred. Capitalized costs include payroll and payroll-related costs for employees and external consulting fees in the Company’s development directly associated with the Company’s internal-use software projects. Capitalization begins when the planning stage is complete and the Company commits resources to the software project and capitalization continues during the application development stage. Capitalization ends when the software has been tested and is ready for its intended use. Costs incurred during the planning, training and post-implementation stages of the software development life-cycle are expensed as incurred. When placed into service, the Company amortizes completed internal-use software to cost of revenue over its estimated useful life. Advertising Costs The Company expenses advertising costs as incurred. Advertising expense for the years ended December 31, 2023 2022 Income Taxes The Company follows the liability method under ASC Topic 740 Income Taxes 740” 740 December 31, 2023 December 31, 2022, December 31, 2023 2022, not 13

Note 4 - Recently Issued Accoun

Note 4 - Recently Issued Accounting Standards	12 Months Ended
Note 4 - Recently Issued Accounting Standards	Dec. 31, 2023
Notes to Financial Statements
Accounting Standards Update and Change in Accounting Principle [Text Block]	Note 4 Recently Issued Accounting Standards Recently adopted accounting pronouncements In June 2016, 2016 13, 326 2016 13” 2016 13 November 2019, 2016 13 December 15, 2022. 2016 13 2016 13 January 1, 2023. twelve 2016 13 not Recently issued accounting pronouncements In November 2023, No. 2023 07, 280 2023 07 2023 07 December 15, 2023, December 15, 2024, In December 2023, No. 2023 09, 2023 09 2023 09 December 15, 2024,

Note 5 - Fair Value Measurement

Note 5 - Fair Value Measurements	12 Months Ended
Note 5 - Fair Value Measurements	Dec. 31, 2023
Notes to Financial Statements
Fair Value Disclosures [Text Block]	Note 5 Fair Value Measurements The Company follows the provisions of FASB ASC Topic 820, Fair Value Measurement and Disclosures 820” three first two • Level 1 • Level 2 1 not • Level 3 no The assigned level within the fair value hierarchy is based on the lowest level of any input that is significant to the fair value measurement. Money market funds included in cash and cash equivalents in the accompanying balance sheet are considered a Level 1 The following table sets forth the Company’s assets which are measured at fair value on a recurring basis by level within the fair value hierarchy (in thousands): Fair Value Measurements (in thousands) as of December 31, 2023 Level 1 Level 2 Level 3 Total Assets Money market accounts $ 15,475 $ — $ — $ 15,475 Total Assets $ 15,475 $ — $ — $ 15,475 Fair Value Measurements (in thousands) as of December 31, 2022 Level 1 Level 2 Level 3 Total Assets Money market accounts $ 15,067 $ — $ — $ 15,067 Total Assets $ 15,067 $ — $ — $ 15,067 There were no Level 3 December 31, 2023 December 31, 2022 Items Measured at Fair Value on a Nonrecurring Basis Certain assets, including long-lived assets and goodwill, are measured at fair value on a nonrecurring basis. These assets are recognized at fair value when they are deemed to be impaired. There were no items measured at fair value on a nonrecurring basis as of or during the years ended December 31, 2023 2022

Note 6 - Revenue

Note 6 - Revenue	12 Months Ended
Note 6 - Revenue	Dec. 31, 2023
Notes to Financial Statements
Revenue from Contract with Customer [Text Block]	Note 6 Revenue Disaggregation of Revenue The following tables presents the Company’s revenues disaggregated by major product or service line, timing of revenue recognition and sales channel, reconciled to its reportable segments (in thousands). Years ended December 31, Reportable Segments Detection 2023 2022 Major Product/Service Lines Products $ 9,930 $ 12,620 Services 7,388 7,182 $ 17,318 $ 19,802 Timing of Revenue Recognition Goods transferred at a point in time $ 8,015 $ 12,545 Services transferred over time 9,303 7,257 $ 17,318 $ 19,802 Sales Channels Direct sales force $ 11,634 $ 12,468 OEM partners 5,684 7,334 $ 17,318 $ 19,802 Contract Balances Contract liabilities are a component of deferred revenue, current contract assets are a component of prepaid and other assets and non-current contract assets are a component of other assets. The following table provides information about receivables, current and non-current contract assets, and contract liabilities from contracts with customers (in thousands). Balance at December 31, 2023 Balance at December 31, 2022 Balance at December 31, 2021 Receivables, which are included in ‘Trade accounts receivable’ $ 6,392 $ 5,769 $ 4,263 Current contract assets, which are included in “Prepaid and other assets” $ — $ 748 $ 1,895 Non-current contract assets, which are included in “other assets” $ 157 $ 15 $ 844 Contract liabilities, which are included in “Deferred revenue” $ 4,374 $ 4,046 $ 3,621 The Company records a receivable when revenue is recognized prior to receipt of cash payments and the Company has the unconditional right to such consideration, or deferred revenue when cash payments are received or due in advance of performance. For multi-year agreements, the Company generally invoices customers annually at the beginning of each annual service period. The Company records net contract assets or contract liabilities on a contract-by-contract basis. The Company records a contract asset for unbilled revenue when the Company’s performance exceeds amounts billed or billable. The Company classifies the net contract asset as either current or non-current based on the expected timing of the Company’s right to bill under the terms of the contract. The current contract asset balance primarily relates to the net unbilled revenue balances with two one two one Contract liabilities, or deferred revenue from contracts with customers, is primarily composed of fees related to long-term service arrangements, which are generally billed in advance. Deferred revenue also includes payments for installation and training that has not Changes in deferred revenue from contracts with customers were as follows (in thousands): Year Ended December 31, 2023 Year Ended December 31, 2022 Balance at beginning of period $ 4,046 $ 3,621 Deferral of revenue 7,669 8,546 Recognition of deferred revenue (7,341 ) (8,121 ) Balance at end of period $ 4,374 $ 4,046 The Company expects to recognize estimated revenues related to performance obligations that are unsatisfied (or partially satisfied) in the amounts of approximately $3.4 million over the next 12 months. The remainder of the balances is expected to be recognized over the next two three Assets Recognized from the Costs to Obtain a Contract with a Customer The Company recognizes an asset for the incremental costs of obtaining a contract with a customer if it expects the benefit of those costs to be longer than one December 31, 2023 2022, no

Note 7 - Net Loss Per Common Sh

Note 7 - Net Loss Per Common Share	12 Months Ended
Note 7 - Net Loss Per Common Share	Dec. 31, 2023
Notes to Financial Statements
Earnings Per Share [Text Block]	Note 7 Net Loss per Common Share The Company follows FASB ASC 260 10, “Earnings per Share” A summary of the Company’s calculation of net loss per share is as follows (in thousands, except per share amounts): 2023 2022 Loss from continuing operations $ (7,010 ) $ (9,918 ) Income (loss) from discontinued operations 2,163 (3,738 ) Net loss $ (4,847 ) $ (13,656 ) Basic shares used in the calculation of earnings per share 25,613 25,202 Effect of dilutive securities: Stock options — — Restricted stock — — Diluted shares used in the calculation of earnings per share 25,613 25,202 Net loss per share (Basic and Diluted): Loss from continuing operations $ (0.27 ) $ (0.39 ) Income (loss) from discontinued operations 0.08 (0.15 ) Net loss per share (Basic and Diluted) $ (0.19 ) $ (0.54 ) The following table summarizes the number of shares of common stock options that were not Year Ended December 31, 2023 2022 Common stock options 2,897,663 2,610,659

Note 8 - Accounts Receivable Re

Note 8 - Accounts Receivable Reserves	12 Months Ended
Note 8 - Accounts Receivable Reserves	Dec. 31, 2023
Notes to Financial Statements
Allowance for Credit Losses [Text Block]	Note 8 Accounts Receivable Reserves The rollforward of the Company’s allowance for credit losses related to its accounts receivable for the years ended December 31 2023 2022 Balance at beginning of period $ 100 $ 97 Additions charged to costs and expenses 177 77 Reductions — (74 ) Balance at end of period $ 277 $ 100

Note 9 - Inventories

Note 9 - Inventories	12 Months Ended
Note 9 - Inventories	Dec. 31, 2023
Notes to Financial Statements
Inventory Disclosure [Text Block]	Note 9 Inventories Inventory balances at December 31, 2023 2022 December 31, 2023 December 31, 2022 Raw materials $ 583 $ 1,427 Work in process 55 184 Finished Goods 324 488 Inventory Gross 962 2,099 Inventory Reserve (45 ) (45 ) Inventory Net $ 917 $ 2,054

Note 10 - Goodwill and Intangib

Note 10 - Goodwill and Intangible Assets	12 Months Ended
Note 10 - Goodwill and Intangible Assets	Dec. 31, 2023
Notes to Financial Statements
Goodwill and Intangible Assets Disclosure [Text Block]	Note 10 Goodwill and Intangible assets At December 31, 2023 2022 December 31, 2023 2022 Amortization expense related to intangible assets was approximately $116,000 and $128,000 for the years ended December 31, 2023 2022, not Weighted average useful life 2023 2022 (in years) Gross Carrying Amount Patents and licenses $ 626 $ 626 5 Technology 7,477 7,477 10 Customer relationships 272 272 7 Tradename 261 261 10 Total amortizable intangible assets 8,636 8,636 Accumulated Amortization Patents and licenses $ 540 $ 537 Technology 7,471 7,387 Customer relationships 217 189 Tradename 260 259 Total accumulated amortization 8,488 8,372 Total amortizable intangible assets, net $ 148 $ 264 Estimated remaining amortization of the Company’s intangible assets is as follows (in thousands): Estimated For the years ended amortization December 31: expense 2024 30 2025 29 2026 1 2027 1 2028 and thereafter 87 $ 148 Included within the line item "2028 not

Note 11 - Accrued and Other Exp

Note 11 - Accrued and Other Expenses	12 Months Ended
Note 11 - Accrued and Other Expenses	Dec. 31, 2023
Notes to Financial Statements
Accounts Payable and Accrued Liabilities Disclosure [Text Block]	Note 11 Accrued and Other expenses Accrued and other expenses consist of the following at December 31 2023 2022 Accrued salary and related expenses $ 952 $ 725 Accrued accounts payable 1,036 1,307 Accrued professional fees 227 400 Accrued royalties and related 213 56 Other accrued expenses 20 53 $ 2,448 $ 2,541

Note 12 - Leases

Note 12 - Leases	12 Months Ended
Note 12 - Leases	Dec. 31, 2023
Notes to Financial Statements
Lessee, Operating Leases [Text Block]	Note 12 Leases The Company has leases for office space, office equipment, and a warehouse. The leases expire at various dates through 2027. November 2022, January 2024, March 2024 February 1, 2024 2027. Year Ended December 31, Lease Cost Classification 2023 2022 Operating lease cost - Right of Use Operating expenses $ 247 $ 209 Operating lease cost - Variable Costs Operating expenses 51 66 Total $ 298 $ 275 Year Ended December 31, 2023 2022 Cash paid for operating cash flows from operating leases $ 257 $ 242 As of December 31, 2023 2022 Weighted-average remaining lease term of operating leases (in years) 1.92 2.52 Weighted-average discount rate for operating leases 6.79 % 6.79 % Maturities of the Company’s lease liabilities as of December 31, 2023 Year Ended December 31: Total 2024 219 2025 204 2026 85 Total lease payments 508 Less: effects of discounting (47 ) Total lease liabilities 461 Less: current portion of lease liabilities (188 ) Long-term lease liabilities $ 273

Note 13 - Stockholders' Equity

Note 13 - Stockholders' Equity	12 Months Ended
Note 13 - Stockholders' Equity	Dec. 31, 2023
Notes to Financial Statements
Equity [Text Block]	Note 13 Stockholders Equity (a) Financing Activity On August 11, 2023, may 415 December 31, 2023, December 31, 2023, not (b) Stock Options The Company's 2016 “2016 may 2016 not 2016 may At the Company’s 2021 2016 December 31, 2023 2016 Weighted Average Remaining Number of Weighted Average Contractual Term Shares Exercise Price (in years) Outstanding, December 31, 2022 2,610,992 $ 7.54 3.76 Granted 1,467,574 $ 1.81 Exercised (35,809 ) $ 2.24 Forfeited (1,145,094 ) $ 5.35 Outstanding, December 31, 2023 2,897,663 $ 5.57 5.45 Exercisable at December 31, 2022 1,906,189 $ 7.59 Exercisable at December 31, 2023 1,593,935 $ 8.08 The Company’s stock-based compensation expense, including options and restricted stock by category is as follows (amounts in thousands): Year Ended December 31, 2023 2022 Cost of revenue $ 2 $ 3 Engineering and product development 222 220 Marketing and sales 308 518 General and administrative expense 784 945 $ 1,316 $ 1,686 As of December 31, 2023 During the first December 31, 2023 , five four 2023. one 60 24 Options granted under the stock incentive plans were valued utilizing the Black-Scholes model using the following assumptions and had the following fair values: Year Ended December 31, 2023 2022 Average risk-free interest rate 4.36 % 2.29 % Expected dividend yield None None Expected life (in years) 2.9 3.5 Expected volatility 72.69 - 134.37 % 66.30 - 72.04 % Weighted average fair value $ 0.98 $ 2.33 The Company’s 2023 2022 zero no not Intrinsic values of options (in thousands) and the closing market price used to determine the intrinsic values are as follows: Intrinsic value of stock options Year Ended December 31, 2023 2022 Outstanding $ 252 $ — Exercisable $ 30 $ — Exercised $ 2 $ — Company’s stock price at December 31 $ 1.77 $ 1.83 As of December 31, 2022, zero (c) Employee Stock Purchase Program: In December 2019, 2019 January 1, 2020. may Substantially all of the Company’s employees whose customary employment is for more than 20 Any eligible employee can enroll in the Plan as of the beginning of a respective quarterly accumulation period. Employees who participate in the ESPP may first no may The Company issued zero December 31, 2023 2022 December 31, 2023 October 2022, October 1, 2022 December 31, 2022 not

Note 14 - Income Taxes

Note 14 - Income Taxes	12 Months Ended
Note 14 - Income Taxes	Dec. 31, 2023
Notes to Financial Statements
Income Tax Disclosure [Text Block]	Note 14 Income Taxes Income Taxes The components of income tax expense for the years ended December 31 2023 2022 Current provision: Federal $ — $ — State — — Foreign — — $ — $ — Deferred provision: Federal $ 1 $ — State — — Foreign 19 (116 ) $ 20 $ (116 ) Total $ 20 $ (116 ) A summary of the differences between the Company’s effective income tax rate and the Federal statutory income tax rate for the years ended December 31 2023 2022 Federal statutory rate 21.0 % 21.0 % State income taxes, net of federal benefit 3.7 % 2.5 % Net state impact of deferred rate change 0.2 % (1.0 )% Stock compensation expense (4.2 )% (0.7 )% Other permanent differences (0.6 )% (0.4 )% Change in valuation allowance 0.6 % (13.7 )% Tax credits 0.5 % 2.0 % Accrual to tax return 0.2 % 0.0 % Foreign Rate Differential 0.0 % 0.0 % True Ups - NOL Expiration/162(m) limits (21.8 )% (8.9 )% Other 0.3 % 0.0 % Effective income tax (0.1 )% 0.8 % Deferred tax assets and liabilities are recognized for the expected future tax consequences of net operating loss carryforwards, tax credit carryforwards and temporary differences between the financial statement carrying amounts and the income tax basis of assets and liabilities. A valuation allowance is applied against any net deferred tax asset if, based on the available evidence, it is more likely than not not Deferred income taxes reflect the impact of “temporary differences” between the amount of assets and liabilities for financial reporting purposes and such amounts as measured by tax laws and regulations. The Company has fully reserved the U.S. net deferred tax assets, as it is more likely than not not not not December 31, 2023 2022 2023 2022 Inventory (Section 263A) $ 97 $ 311 Inventory reserves 15 61 Bad debt reserves 68 215 Other accruals 242 813 Deferred revenue 549 129 Accumulated depreciation/amortization — 17 Stock options 1,127 1,108 Developed technology 205 976 Tax credits 4,480 4,427 NOL carryforward 38,263 38,234 Lease Liability 113 792 Section 174 R&D 2,425 1,749 Deferred tax assets 47,584 48,832 Valuation allowance (47,364 ) (47,930 ) Right of Use Asset (113 ) (786 ) Accumulated depreciation/amortization (10 ) — Goodwill tax amortization (7 ) (6 ) Net deferred tax asset (liability) $ 90 $ 110 The decrease in the net deferred tax assets and corresponding valuation allowance during the year ended December 31, 2023 As of December 31, 2023, 2024 2037. December 31, 2017 December 31, 2023, December 31, 2023, December 31, 2022, not may The Company currently has approximately $4.6 million in net operating losses that are subject to limitations related to its former Xoft business line. Approximately $656,000 can be used annually through 2029. 1986 2042. no 2030. ASC 740 10 As of December 31, 2023 2022 no 740 10. zero December 31, 2023 2022. three not The Company does not December 31, 2023 12

Note 15 - Segment Reporting

Note 15 - Segment Reporting	12 Months Ended
Note 15 - Segment Reporting	Dec. 31, 2023
Notes to Financial Statements
Segment Reporting Disclosure [Text Block]	Note 15 Segment Reporting (a) Segment Reporting The Company manages and operates as one business: Detection, which consists of the Company's advanced image analysis and workflow products. The business operations are managed by a single executive leadership team, which is led by the chief executive officer, who the Company has concluded is the Chief Operating Decision Maker ("CODM"). The Company does not not not one (b) Geographic Information The Company’s sales are made to customers and distributors of mammography medical equipment. Outside of the US, revenues to a single country did not 10% 2023 2022 As of December 31, 2023 2022 Percent of Export sales Region 2023 2022 Europe 10 % 11 % All other 3 % 6 % Total 13 % 17 % Total Export Revenue $ 2,333 $ 3,312 Significant export sales in Europe are as follows: Percent of Export sales Region 2023 2022 France 64 % 52 % Belgium 13 % 10 % Italy 6 % 12 % Germany 4 % 8 % Switzerland 4 % 9 % All other 9 % 9 % (c) Major Customers The Company had one 2023 2022, December 31, 2023 no December 31, 2023 December 31, 2022 one December 31, 2023 December 31, 2022. OEM partners represented $1.6 million or 28% of outstanding receivables as of December 31, 2023 December 31, 2023 December 31, 2023

Note 16 - Commitments and Conti

Note 16 - Commitments and Contingencies	12 Months Ended
Note 16 - Commitments and Contingencies	Dec. 31, 2023
Notes to Financial Statements
Commitments and Contingencies Disclosure [Text Block]	Note 16 Commitments and Contingencies (a) Purchase Commitments The Company has non-cancelable purchase orders with key suppliers executed in the normal course of business that total approximately $0.7 million. (b) Employment Agreements The Company has entered into employment agreements with certain executives and key employees. The employment agreements provide for minimum severance payments, performance-based annual bonus compensation, and accelerated vesting of equity awards upon certain provisions, as defined in their respective agreements, in the event that their employment is terminated without cause and/or upon change in control. (c) Royalty Obligations In connection with prior litigation, the Company received a nonexclusive, irrevocable, perpetual, worldwide license, including the right to sublicense certain Hologic patents, and a non-compete covenant as well as an agreement not 2016. four (d) Legal Matters In addition to the foregoing, the Company may no may not 450,

Note 17 - Employee Benefit Plan

Note 17 - Employee Benefit Plan	12 Months Ended
Note 17 - Employee Benefit Plan	Dec. 31, 2023
Notes to Financial Statements
Defined Benefit Plan [Text Block]	Note 17 Employee Benefit Plan The Company has a 401 “401 may 401 not December 31, 2023 2022

Note 18 - Subsequent Events

Note 18 - Subsequent Events	12 Months Ended
Note 18 - Subsequent Events	Dec. 31, 2023
Notes to Financial Statements
Subsequent Events [Text Block]	18 Subsequent Events As more fully described in Note 12, January 2024, March 2024 36 February 1, 2024 2027. not

Significant Accounting Policies

Significant Accounting Policies (Policies)	12 Months Ended
Significant Accounting Policies (Policies)	Dec. 31, 2023
Accounting Policies [Abstract]
Use of Estimates, Policy [Policy Text Block]	Use of Estimates The preparation of financial statements in conformity with generally accepted accounting principles in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses during the reporting period and disclosure of contingent assets and liabilities at the date of the financial statements. Actual results could differ from those estimates. It is reasonably possible that changes may
Consolidation, Policy [Policy Text Block]	Principles of Consolidation The consolidated financial statements include the accounts of the Company and its wholly owned subsidiary, iCAD France, LLC. As described in Note 2, October 2023.
Concentration Risk, Credit Risk, Policy [Policy Text Block]	Risk and Uncertainty On March 12, 2020, 19 19, December 31, 2023, 19 In late February 2022, October 2023, Sustained conflict and disruption in these regions has continued through December 31, 2023 may may may not 2023, 10%
Cash and Cash Equivalents, Policy [Policy Text Block]	Cash and cash equivalents The Company defines cash and cash equivalents as all bank accounts, money market funds, deposits and other money market instruments with original maturities of 90 may $250,000 5 not not December 31, 2023, not
Fair Value of Financial Instruments, Policy [Policy Text Block]	Financial instruments Financial instruments consist of cash and cash equivalents, trade accounts receivable, contract assets, accounts payable, accrued and other expenses and notes payable. Due to their short-term nature and market rates of interest, the carrying amounts of the financial instruments approximated fair value as of December 31, 2023 2022
Receivables, Trade and Other Accounts Receivable, Allowance for Doubtful Accounts, Policy [Policy Text Block]	Accounts Receivable and Allowance for Credit Losses Accounts receivable are customer obligations due under normal trade terms. Credit limits are initially established through a process of reviewing the financial history and stability of each customer and the Company performs continuing credit evaluations of its customers’ financial condition and generally does not December 31, 2023 2024 December 31, 2022. one three As described in Note 4, January 1, 2023 twelve December 31, 2023 2022
Inventory, Policy [Policy Text Block]	Inventory The Company uses the first first
Property, Plant and Equipment, Policy [Policy Text Block]	Property and Equipment Property and equipment are stated at cost and depreciated using the straight-line method over the estimated useful lives of the assets, which is generally three five
Goodwill and Intangible Assets, Goodwill, Policy [Policy Text Block]	Goodwill In accordance with FASB Accounting Standards Codification (“ASC”) Topic 350 20, “Intangibles Goodwill and Other 350 20” not Factors the Company considers important, which could trigger an impairment of Goodwill, include the following: • significant and sustained underperformance relative to historical or projected future operating results; • significant changes in the manner or use of the Company’s assets in the strategy for the Company’s overall business; • significant negative industry or economic trends; • significant and sustained decline in the Company’s stock price; and • a decline in the Company’s market capitalization below net book value. Upon the sale of its former Xoft business, the Company has one The Company performs an annual impairment assessment as of October 1 may 2023, October 1, 2023, no 2023, Fair value of the reporting unit is based on a weighting of the income approach and the market approach. For purposes of the income approach, fair value is determined based on the present value of estimated future cash flows, discounted at an appropriate risk adjusted rate. The Company uses internal forecasts to estimate future cash flows and includes estimates of long-term future growth rates based on our most recent views of the long-term forecast for each segment. Accordingly, actual results can differ from those assumed in our forecasts. Discount rates are derived from a capital asset pricing model and by analyzing published rates for industries relevant to our reporting units to estimate the cost of equity financing. The Company uses discount rates that are commensurate with the risks and uncertainty inherent in the respective businesses and in our internally developed forecasts. In the market approach, the Company uses a valuation technique in which values are derived based on market prices of publicly traded companies with similar operating characteristics and industries. A market approach allows for comparison to actual market transactions and multiples. It can be somewhat limited in its application because the population of potential comparable publicly-traded companies can be limited due to differing characteristics of the comparative business and ours, as well as the fact that market data may not may The Company corroborates the total fair values of the reporting unit using a market capitalization approach since it now operates with only one may not
Impairment or Disposal of Long-Lived Assets, Including Intangible Assets, Policy [Policy Text Block]	Long Lived Assets In accordance with FASB ASC Topic 360, 360” not ASC 360 10 35 no 360 10 35 21 may not • A significant decrease in the market price of a long-lived asset (asset group); • A significant adverse change in the extent or manner in which a long-lived asset (asset group) is being used or in its physical condition; • A significant adverse change in legal factors or in the business climate that could affect the value of a long-lived asset (asset group), including an adverse action or assessment by a regulator; • An accumulation of costs significantly in excess of the amount originally expected for the acquisition or construction of a long-lived asset (asset group); • A current period operating or cash flow loss combined with a history of operating or cash flow losses or a projection or forecast that demonstrates continuing losses associated with the use of a long-lived asset (asset group); • significant and sustained decline in the Company’s stock price. In accordance with ASC 360 10 35 17, not The Company did not December 31, 2023 December 31, 2022 Intangible assets subject to amortization consist primarily of patents, technology intangibles, trade names, customer relationships and distribution agreements purchased in the Company’s previous acquisitions. These assets are amortized on a straight-line basis or the pattern of economic benefit over their estimated useful lives of 5 to 10 years.
Lessee, Leases [Policy Text Block]	Leases In accordance with FASB ASC Topic 842, 842" At lease inception, the Company recognizes a lease liability equal to the present value of the remaining lease payments, and a right of use asset equal to the lease liability, subject to certain adjustments, such as for lease incentives. In determining the present value of the lease payments, the Company uses its incremental borrowing rate, determined by estimating the Company’s applicable, fully collateralized borrowing rate, with adjustment as appropriate for lease term. The lease term at the lease commencement date is determined based on the non-cancellable period for which the Company has the right to use the underlying asset, together with any periods covered by an extension option if the Company is reasonably certain to exercise that option. Right-of-use assets and obligations for leases with an initial term of 12 not not third not 606, 606" ASC 842 no December 31, 2023 Certain of the Company’s leases include variable lease costs to reimburse the lessor for real estate tax and insurance expenses, and certain non-lease components that transfer a distinct service to the Company, such as common area maintenance services. The Company has elected to separate the accounting for lease components and non-lease components for real estate and equipment leases.
Share-Based Payment Arrangement [Policy Text Block]	Stock-Based Compensation The Company maintains stock-based incentive plans, under which it provides stock incentives to employees, directors and contractors. The Company grants to employees, directors and contractors, options to purchase common stock at an exercise price equal to the market value of the stock at the date of grant. The Company may not 718, “Compensation Stock Compensation 718” The Company uses the Black-Scholes option pricing model to value stock options which requires extensive use of accounting judgment and financial estimates, including estimates of the expected term participants will retain their vested stock options before exercising them, the estimated volatility of its common stock price over the expected term, and the number of options that will be forfeited prior to the completion of their vesting requirements. The Company estimates forfeitures based on historical experience with pre-vested forfeitures. To the extent actual forfeitures differ from the estimate, the difference is recorded to compensation expense in the period of the forfeiture. Fair value of restricted stock is determined based on the stock price of the underlying option on the date of the grant. Application of alternative assumptions could produce significantly different estimates of the fair value of stock-based compensation and consequently, the related amounts recognized in the Consolidated Statements of Operations.
Revenue [Policy Text Block]	Revenue Recognition In accordance with ASC 606, may The Company applies the following five 1 Identify the contract(s) with a customer may not 2 Identify the performance obligations in the contract third not not 3 Determine the transaction price not 4 Allocate the transaction price to the performance obligations in the contract not 5 Recognize revenue when (or as) the Company satisfies a performance obligation The Company recognizes revenue from its contracts with customers primarily from the sale of products and from the sale of services. Revenue is recognized when control of the promised goods or services is transferred to a customer, in an amount that reflects the consideration the Company expects to be entitled to in exchange for those goods or services. For iCAD’s typical product revenue, control typically transfers upon shipment as title and risk of loss have passed to the customer. Services and supplies are considered to be transferred as the services are performed or over the term of the service or supply agreement. The Company enters into contracts that can include various combinations of products and services, which are generally capable of being distinct and accounted for as separate performance obligations. Perpetual software licenses are accounted for as a single performance obligation and revenue is recognized at the point in time when ownership is transferred to the customer. Taxes assessed by a governmental authority that are both imposed on and concurrent with a specific revenue-producing transaction, that are collected by the Company from a customer, are excluded from revenue. Shipping and handling costs associated with outbound freight after control of a product has transferred to a customer are accounted for as fulfillment costs and are included in cost of revenue. The Company continues to provide for estimated warranty costs on original product warranties at the time of sale. Goods and Services Classifications Products Service Contracts 12 48 Professional Services Other For all of contracts, payment terms are generally net 30 Significant Judgments The Company’s contracts with customers may may one may The Company may not Assets Recognized from the Costs to Obtain a Contract with a Customer The Company recognizes incremental costs of obtaining a contract with a customer as an asset if the Company expects the benefit of those costs to be longer than one one Right to Invoice Where applicable, the Company recognizes revenue from a contract with a customer in an amount that corresponds directly with the value to the customer of the Company’s performance completed to date and the amount to which the Company has a right to invoice. Sales and Other Similar Taxes The Company excludes sales taxes and similar taxes from the measurement of the transaction price. Significant Financing Component The Company does not one Promised Goods or Services that are Immaterial in the Context of a Contract The Company assesses materiality of promised goods or services as performance obligations in the context of a contract and the Company does not 606 The Company does not one
Cost of Goods and Service [Policy Text Block]	Cost of Revenue Cost of revenue consists of the costs of products purchased for resale, cost relating to service including costs of service contracts to maintain equipment after the warranty period, inbound freight and duty, manufacturing, warehousing, material movement, inspection, scrap, rework, depreciation and in-house product warranty repairs, amortization of acquired technology and any applicable medical device tax.
Standard Product Warranty, Policy [Policy Text Block]	Warranty Costs The Company provides for the estimated cost of standard product warranty against defects in material and workmanship based on historical warranty trends, including the cost of product returns during the warranty period. Warranty costs have not
Research and Development Expense, Policy [Policy Text Block]	Engineering and Product Development Costs and Capitalized Internal-Use Software Costs Engineering and product development costs relate to research and development efforts including Company sponsored clinical trials are expensed as incurred. Capitalized costs include payroll and payroll-related costs for employees and external consulting fees in the Company’s development directly associated with the Company’s internal-use software projects. Capitalization begins when the planning stage is complete and the Company commits resources to the software project and capitalization continues during the application development stage. Capitalization ends when the software has been tested and is ready for its intended use. Costs incurred during the planning, training and post-implementation stages of the software development life-cycle are expensed as incurred. When placed into service, the Company amortizes completed internal-use software to cost of revenue over its estimated useful life.
Advertising Cost [Policy Text Block]	Advertising Costs The Company expenses advertising costs as incurred. Advertising expense for the years ended December 31, 2023 2022
Income Tax, Policy [Policy Text Block]	Income Taxes The Company follows the liability method under ASC Topic 740 Income Taxes 740” 740 December 31, 2023 December 31, 2022, December 31, 2023 2022, not 13

Note 2 - Discontinued Operati_2

Note 2 - Discontinued Operations (Tables)	12 Months Ended
Note 2 - Discontinued Operations (Tables)	Dec. 31, 2023
Notes Tables
Disposal Groups, Including Discontinued Operations [Table Text Block]	For the period ended October 22, For the year ended December 31, 2023 2022 Revenue $ 4,804 $ 8,142 Total cost of sales 2,580 5,152 Gross profit $ 2,224 $ 2,990 Total operating expenses 2,653 6,728 Pre-tax loss from operations of discontinued business (429 ) (3,738 ) Provision for income taxes — — Loss from operations of discontinued business $ (429 ) $ (3,738 ) Gain on sale of discontinued operations 2,592 — Provision for income taxes on gain on sale — — Income (loss) from discontinued operations, net of tax $ 2,163 $ (3,738 ) December 31, 2022 Assets Accounts receivable, net of allowance for credit losses $ 3,129 Inventories, net 3,335 Prepaid expenses and other current assets 1,070 Total current assets held for sale $ 7,534 Net property and equipment $ 370 Operating lease assets 2,691 Other assets 268 Total noncurrent assets held for sale $ 3,329 Liabilities Accounts payable $ 527 Accrued and other expenses 2,140 Lease payable - current portion 365 Deferred revenue - current portion 2,563 Total current liabilities held for sale $ 5,595 Lease payable, net of current 2,348 Deferred revenue, net of current 149 Noncurrent liabilities held for sale $ 2,497

Note 5 - Fair Value Measureme_2

Note 5 - Fair Value Measurements (Tables)	12 Months Ended
Note 5 - Fair Value Measurements (Tables)	Dec. 31, 2023
Notes Tables
Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]	Fair Value Measurements (in thousands) as of December 31, 2023 Level 1 Level 2 Level 3 Total Assets Money market accounts $ 15,475 $ — $ — $ 15,475 Total Assets $ 15,475 $ — $ — $ 15,475 Fair Value Measurements (in thousands) as of December 31, 2022 Level 1 Level 2 Level 3 Total Assets Money market accounts $ 15,067 $ — $ — $ 15,067 Total Assets $ 15,067 $ — $ — $ 15,067

Note 6 - Revenue (Tables)

Note 6 - Revenue (Tables)	12 Months Ended
Note 6 - Revenue (Tables)	Dec. 31, 2023
Notes Tables
Disaggregation of Revenue [Table Text Block]	Years ended December 31, Reportable Segments Detection 2023 2022 Major Product/Service Lines Products $ 9,930 $ 12,620 Services 7,388 7,182 $ 17,318 $ 19,802 Timing of Revenue Recognition Goods transferred at a point in time $ 8,015 $ 12,545 Services transferred over time 9,303 7,257 $ 17,318 $ 19,802 Sales Channels Direct sales force $ 11,634 $ 12,468 OEM partners 5,684 7,334 $ 17,318 $ 19,802
Contract with Customer, Contract Asset, Contract Liability, and Receivable [Table Text Block]	Balance at December 31, 2023 Balance at December 31, 2022 Balance at December 31, 2021 Receivables, which are included in ‘Trade accounts receivable’ $ 6,392 $ 5,769 $ 4,263 Current contract assets, which are included in “Prepaid and other assets” $ — $ 748 $ 1,895 Non-current contract assets, which are included in “other assets” $ 157 $ 15 $ 844 Contract liabilities, which are included in “Deferred revenue” $ 4,374 $ 4,046 $ 3,621
Deferred Revenue, by Arrangement, Disclosure [Table Text Block]	Year Ended December 31, 2023 Year Ended December 31, 2022 Balance at beginning of period $ 4,046 $ 3,621 Deferral of revenue 7,669 8,546 Recognition of deferred revenue (7,341 ) (8,121 ) Balance at end of period $ 4,374 $ 4,046

Note 7 - Net Loss Per Common _2

Note 7 - Net Loss Per Common Share (Tables)	12 Months Ended
Note 7 - Net Loss Per Common Share (Tables)	Dec. 31, 2023
Notes Tables
Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]	2023 2022 Loss from continuing operations $ (7,010 ) $ (9,918 ) Income (loss) from discontinued operations 2,163 (3,738 ) Net loss $ (4,847 ) $ (13,656 ) Basic shares used in the calculation of earnings per share 25,613 25,202 Effect of dilutive securities: Stock options — — Restricted stock — — Diluted shares used in the calculation of earnings per share 25,613 25,202 Net loss per share (Basic and Diluted): Loss from continuing operations $ (0.27 ) $ (0.39 ) Income (loss) from discontinued operations 0.08 (0.15 ) Net loss per share (Basic and Diluted) $ (0.19 ) $ (0.54 )
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]	Year Ended December 31, 2023 2022 Common stock options 2,897,663 2,610,659

Note 8 - Accounts Receivable _2

Note 8 - Accounts Receivable Reserves (Tables)	12 Months Ended
Note 8 - Accounts Receivable Reserves (Tables)	Dec. 31, 2023
Notes Tables
Financing Receivable, Current, Allowance for Credit Loss [Table Text Block]	2023 2022 Balance at beginning of period $ 100 $ 97 Additions charged to costs and expenses 177 77 Reductions — (74 ) Balance at end of period $ 277 $ 100

Note 9 - Inventories (Tables)

Note 9 - Inventories (Tables)	12 Months Ended
Note 9 - Inventories (Tables)	Dec. 31, 2023
Notes Tables
Schedule of Inventory, Current [Table Text Block]	December 31, 2023 December 31, 2022 Raw materials $ 583 $ 1,427 Work in process 55 184 Finished Goods 324 488 Inventory Gross 962 2,099 Inventory Reserve (45 ) (45 ) Inventory Net $ 917 $ 2,054

Note 10 - Goodwill and Intang_2

Note 10 - Goodwill and Intangible Assets (Tables)	12 Months Ended
Note 10 - Goodwill and Intangible Assets (Tables)	Dec. 31, 2023
Notes Tables
Schedule of Finite-Lived Intangible Assets [Table Text Block]	Weighted average useful life 2023 2022 (in years) Gross Carrying Amount Patents and licenses $ 626 $ 626 5 Technology 7,477 7,477 10 Customer relationships 272 272 7 Tradename 261 261 10 Total amortizable intangible assets 8,636 8,636 Accumulated Amortization Patents and licenses $ 540 $ 537 Technology 7,471 7,387 Customer relationships 217 189 Tradename 260 259 Total accumulated amortization 8,488 8,372 Total amortizable intangible assets, net $ 148 $ 264
Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]	Estimated For the years ended amortization December 31: expense 2024 30 2025 29 2026 1 2027 1 2028 and thereafter 87 $ 148

Note 11 - Accrued and Other E_2

Note 11 - Accrued and Other Expenses (Tables)	12 Months Ended
Note 11 - Accrued and Other Expenses (Tables)	Dec. 31, 2023
Notes Tables
Schedule of Accounts Payable and Accrued Liabilities [Table Text Block]	2023 2022 Accrued salary and related expenses $ 952 $ 725 Accrued accounts payable 1,036 1,307 Accrued professional fees 227 400 Accrued royalties and related 213 56 Other accrued expenses 20 53 $ 2,448 $ 2,541

Note 12 - Leases (Tables)

Note 12 - Leases (Tables)	12 Months Ended
Note 12 - Leases (Tables)	Dec. 31, 2023
Notes Tables
Lease, Cost [Table Text Block]	Year Ended December 31, Lease Cost Classification 2023 2022 Operating lease cost - Right of Use Operating expenses $ 247 $ 209 Operating lease cost - Variable Costs Operating expenses 51 66 Total $ 298 $ 275 Year Ended December 31, 2023 2022 Cash paid for operating cash flows from operating leases $ 257 $ 242 As of December 31, 2023 2022 Weighted-average remaining lease term of operating leases (in years) 1.92 2.52 Weighted-average discount rate for operating leases 6.79 % 6.79 %
Financing Lease and Lessee Operating Lease Liability Maturity [Table Text Block]	Year Ended December 31: Total 2024 219 2025 204 2026 85 Total lease payments 508 Less: effects of discounting (47 ) Total lease liabilities 461 Less: current portion of lease liabilities (188 ) Long-term lease liabilities $ 273

Note 13 - Stockholders' Equity

Note 13 - Stockholders' Equity (Tables)	12 Months Ended
Note 13 - Stockholders' Equity (Tables)	Dec. 31, 2023
Notes Tables
Share-Based Payment Arrangement, Option, Activity [Table Text Block]	Weighted Average Remaining Number of Weighted Average Contractual Term Shares Exercise Price (in years) Outstanding, December 31, 2022 2,610,992 $ 7.54 3.76 Granted 1,467,574 $ 1.81 Exercised (35,809 ) $ 2.24 Forfeited (1,145,094 ) $ 5.35 Outstanding, December 31, 2023 2,897,663 $ 5.57 5.45 Exercisable at December 31, 2022 1,906,189 $ 7.59 Exercisable at December 31, 2023 1,593,935 $ 8.08
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]	Year Ended December 31, 2023 2022 Cost of revenue $ 2 $ 3 Engineering and product development 222 220 Marketing and sales 308 518 General and administrative expense 784 945 $ 1,316 $ 1,686
Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]	Year Ended December 31, 2023 2022 Average risk-free interest rate 4.36 % 2.29 % Expected dividend yield None None Expected life (in years) 2.9 3.5 Expected volatility 72.69 - 134.37 % 66.30 - 72.04 % Weighted average fair value $ 0.98 $ 2.33
Summary of Intrinsic Values of Option and Closing Market Price [Table Text Block]	Year Ended December 31, 2023 2022 Outstanding $ 252 $ — Exercisable $ 30 $ — Exercised $ 2 $ — Company’s stock price at December 31 $ 1.77 $ 1.83

Note 14 - Income Taxes (Tables)

Note 14 - Income Taxes (Tables)	12 Months Ended
Note 14 - Income Taxes (Tables)	Dec. 31, 2023
Notes Tables
Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]	2023 2022 Current provision: Federal $ — $ — State — — Foreign — — $ — $ — Deferred provision: Federal $ 1 $ — State — — Foreign 19 (116 ) $ 20 $ (116 ) Total $ 20 $ (116 )
Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]	2023 2022 Federal statutory rate 21.0 % 21.0 % State income taxes, net of federal benefit 3.7 % 2.5 % Net state impact of deferred rate change 0.2 % (1.0 )% Stock compensation expense (4.2 )% (0.7 )% Other permanent differences (0.6 )% (0.4 )% Change in valuation allowance 0.6 % (13.7 )% Tax credits 0.5 % 2.0 % Accrual to tax return 0.2 % 0.0 % Foreign Rate Differential 0.0 % 0.0 % True Ups - NOL Expiration/162(m) limits (21.8 )% (8.9 )% Other 0.3 % 0.0 % Effective income tax (0.1 )% 0.8 %
Schedule of Deferred Tax Assets and Liabilities [Table Text Block]	2023 2022 Inventory (Section 263A) $ 97 $ 311 Inventory reserves 15 61 Bad debt reserves 68 215 Other accruals 242 813 Deferred revenue 549 129 Accumulated depreciation/amortization — 17 Stock options 1,127 1,108 Developed technology 205 976 Tax credits 4,480 4,427 NOL carryforward 38,263 38,234 Lease Liability 113 792 Section 174 R&D 2,425 1,749 Deferred tax assets 47,584 48,832 Valuation allowance (47,364 ) (47,930 ) Right of Use Asset (113 ) (786 ) Accumulated depreciation/amortization (10 ) — Goodwill tax amortization (7 ) (6 ) Net deferred tax asset (liability) $ 90 $ 110

Note 15 - Segment Reporting (Ta

Note 15 - Segment Reporting (Tables)	12 Months Ended
Note 15 - Segment Reporting (Tables)	Dec. 31, 2023
Notes Tables
Revenue from External Customers by Geographic Areas [Table Text Block]	Percent of Export sales Region 2023 2022 Europe 10 % 11 % All other 3 % 6 % Total 13 % 17 % Total Export Revenue $ 2,333 $ 3,312 Percent of Export sales Region 2023 2022 France 64 % 52 % Belgium 13 % 10 % Italy 6 % 12 % Germany 4 % 8 % Switzerland 4 % 9 % All other 9 % 9 %

Note 1 - Organization and Bus_2

Note 1 - Organization and Business (Details Textual)	12 Months Ended
Note 1 - Organization and Business (Details Textual)	Dec. 31, 2023
Number of Operating Segments	1

Note 2 - Discontinued Operati_3

Note 2 - Discontinued Operations (Details Textual) - Disposal Group, Held-for-Sale, Not Discontinued Operations [Member] - Xoft Solutions, LLC [Member] - USD ($) $ in Thousands		12 Months Ended
	Oct. 22, 2023	Dec. 31, 2023	Dec. 31, 2022
Disposal Group, Including Discontinued Operation, Consideration	$ 5,760
Proceeds from Divestiture of Businesses	$ 5,000
Disposal Group, Including Discontinued Operation, Consideration, Period for Holdback Reserve (Month)	15 months
Disposal Group, Including Discontinued Operation, Operating Expense		$ (2,653)	$ (6,728)
Net Cash Provided by (Used in) Discontinued Operations		100	3,600
Shared Marketing Expense [Member] \| Maximum [Member]
Disposal Group, Including Discontinued Operation, Operating Expense		$ 100	$ 600
Other Assets [Member]
Disposal Group, Including Discontinued Operation, Consideration	$ 700

Note 2 - Discontinued Operati_4

Note 2 - Discontinued Operations - Summary of Discontinued Operations (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Income (loss) from discontinued operations, net of tax	$ 2,163	$ (3,738)
Total current assets held for sale	0	7,534
Total noncurrent assets held for sale	0	3,329
Total current liabilities held for sale	0	5,595
Noncurrent liabilities held for sale	0	2,497
Disposal Group, Held-for-Sale, Not Discontinued Operations [Member] \| Xoft Solutions, LLC [Member]
Revenue	4,804	8,142
Total cost of sales	2,580	5,152
Gross profit	2,224	2,990
Total operating expenses	2,653	6,728
Pre-tax loss from operations of discontinued business	(429)	(3,738)
Provision for income taxes	0	0
Loss from operations of discontinued business	(429)	(3,738)
Gain on sale of discontinued operations	2,592	0
Provision for income taxes on gain on sale	0	0
Income (loss) from discontinued operations, net of tax	$ 2,163	(3,738)
Accounts receivable, net of allowance for credit losses		3,129
Inventories, net		3,335
Prepaid expenses and other current assets		1,070
Total current assets held for sale		7,534
Net property and equipment		370
Operating lease assets		2,691
Other assets		268
Total noncurrent assets held for sale		3,329
Accounts payable		527
Accrued and other expenses		2,140
Lease payable - current portion		365
Deferred revenue - current portion		2,563
Total current liabilities held for sale		5,595
Lease payable, net of current		2,348
Deferred revenue, net of current		149
Noncurrent liabilities held for sale		$ 2,497

Note 3 - Significant Accounti_2

Note 3 - Significant Accounting Policies (Details Textual) $ in Thousands	12 Months Ended
	Dec. 31, 2023 USD ($)	Dec. 31, 2022 USD ($)
Unbilled Receivables, Current	$ 900	$ 200
Number of Reporting Units	1
Goodwill, Impairment Loss	$ 0
Impairment, Long-Lived Asset, Held-for-Use, Total	0	0
Advertising Expense	$ 200	$ 400
Minimum [Member]
Unbilled Receivables, Term (Year)	1 year
Finite-Lived Intangible Asset, Useful Life (Year)	5 years
Minimum [Member] \| Leasehold Improvements [Member]
Property, Plant and Equipment, Useful Life (Year)	3 years
Maximum [Member]
Unbilled Receivables, Term (Year)	3 years
Finite-Lived Intangible Asset, Useful Life (Year)	10 years
Maximum [Member] \| Leasehold Improvements [Member]
Property, Plant and Equipment, Useful Life (Year)	5 years

Note 5 - Fair Value Measureme_3

Note 5 - Fair Value Measurements (Details Textual) - USD ($) $ in Thousands	Dec. 31, 2023	Dec. 31, 2022
Fair Value, Nonrecurring [Member]
Assets, Fair Value Disclosure, Total	$ 0	$ 0
Fair Value, Inputs, Level 3 [Member]
Assets, Fair Value Disclosure, Total	$ 0	$ 0

Note 5 - Fair Value Measureme_4

Note 5 - Fair Value Measurements - Assets and Liabilities which are Measured at Fair Value on a Recurring Basis (Details) - USD ($) $ in Thousands	Dec. 31, 2023	Dec. 31, 2022
Fair Value, Inputs, Level 3 [Member]
Assets, fair value	$ 0	$ 0
Fair Value, Recurring [Member]
Assets, fair value	15,475	15,067
Fair Value, Recurring [Member] \| Money Market Funds [Member]
Assets, fair value	15,475	15,067
Fair Value, Recurring [Member] \| Fair Value, Inputs, Level 1 [Member]
Assets, fair value	15,475	15,067
Fair Value, Recurring [Member] \| Fair Value, Inputs, Level 1 [Member] \| Money Market Funds [Member]
Assets, fair value	15,475	15,067
Fair Value, Recurring [Member] \| Fair Value, Inputs, Level 2 [Member]
Assets, fair value	0	0
Fair Value, Recurring [Member] \| Fair Value, Inputs, Level 2 [Member] \| Money Market Funds [Member]
Assets, fair value	0	0
Fair Value, Recurring [Member] \| Fair Value, Inputs, Level 3 [Member]
Assets, fair value	0	0
Fair Value, Recurring [Member] \| Fair Value, Inputs, Level 3 [Member] \| Money Market Funds [Member]
Assets, fair value	$ 0	$ 0

Note 6 - Revenue 1 (Details Tex

Note 6 - Revenue 1 (Details Textual) $ in Millions	Dec. 31, 2023 USD ($)
Revenue, Remaining Performance Obligation, Amount	$ 3.4

Note 6 - Revenue 2 (Details Tex

Note 6 - Revenue 2 (Details Textual) - Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2024-01-01	Dec. 31, 2023
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period (Month)	12 months
Minimum [Member]
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period (Month)	2 years
Maximum [Member]
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period (Month)	3 years

Note 6 - Revenue - Revenues Dis

Note 6 - Revenue - Revenues Disaggregated by Major Good or Service Line, Timing of Revenue Recognition, and Sales Channel, Reconciled to Our Reportable Segments (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Revenue from contracts with customers	$ 17,318	$ 19,802
Direct Sales Force [Member]
Revenue from contracts with customers	11,634	12,468
OEM Partners [Member]
Revenue from contracts with customers	5,684	7,334
Transferred at Point in Time [Member]
Revenue from contracts with customers	8,015	12,545
Transferred over Time [Member]
Revenue from contracts with customers	9,303	7,257
Product [Member]
Revenue from contracts with customers	9,930	12,620
Service Contracts [Member]
Revenue from contracts with customers	$ 7,388	$ 7,182

Note 6 - Revenue - Summary of R

Note 6 - Revenue - Summary of Receivables, Contract Assets and Contract Liabilities from Contracts with Customers (Details) - USD ($) $ in Thousands	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Receivables, which are included in ‘Trade accounts receivable’	$ 6,392	$ 5,769	$ 4,263
Current contract assets, which are included in “Prepaid and other assets”	0	748	1,895
Non-current contract assets, which are included in “other assets”	157	15	844
Contract liabilities, which are included in “Deferred revenue”	$ 4,374	$ 4,046	$ 3,621

Note 6 - Revenue - Summary of C

Note 6 - Revenue - Summary of Changes in Deferred Revenue from Contracts with Customers (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Balance at beginning of period	$ 4,046	$ 3,621
Deferral of revenue	7,669	8,546
Recognition of deferred revenue	(7,341)	(8,121)
Balance at end of period	$ 4,374	$ 4,046

Note 7 - Net Loss Per Common _3

Note 7 - Net Loss Per Common Share - Calculation of Net Loss Per Share (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Loss from continuing operations	$ (7,010)	$ (9,918)
Income (loss) from discontinued operations	2,163	(3,738)
Net loss	$ (4,847)	$ (13,656)
Basic shares used in the calculation of earnings per share (in shares)	25,613	25,202
Stock options (in shares)	0	0
Restricted stock (in shares)	0	0
Diluted shares used in the calculation of earnings per share (in shares)	25,613	25,202
Loss from continuing operations (in dollars per share)	$ (0.27)	$ (0.39)
Income (loss) from discontinued operations (in dollars per share)	0.08	(0.15)
Net loss per share (Basic and Diluted) (in dollars per share)	$ (0.19)	$ (0.54)

Note 7 - Net Loss Per Common _4

Note 7 - Net Loss Per Common Share - Schedule of Anti-dilutive Shares Excluded From Computation of Diluted Net Loss Per Share (Details) - shares	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Share-Based Payment Arrangement, Option [Member]
Common stock options, warrants and restricted stock (in shares)	2,897,663	2,610,659

Note 8 - Accounts Receivable _3

Note 8 - Accounts Receivable Reserves - Schedule of Accounts Receivable Reserves (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Balance	$ 100	$ 97
Additions charged to costs and expenses	177	77
Reductions	0	(74)
Balance	$ 277	$ 100

Note 9 - Inventory - Schedule o

Note 9 - Inventory - Schedule of Current Inventory (Details) - USD ($) $ in Thousands	Dec. 31, 2023	Dec. 31, 2022
Raw materials	$ 583	$ 1,427
Work in process	55	184
Finished Goods	324	488
Inventory Gross	962	2,099
Inventory Reserve	(45)	(45)
Inventory Net	$ 917	$ 2,054

Note 10 - Goodwill and Intang_3

Note 10 - Goodwill and Intangible Assets (Details Textual) - USD ($)	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Goodwill, Ending Balance	$ 8,362,000	$ 8,362,000
Goodwill, Period Increase (Decrease)	0
Amortization of Intangible Assets	$ 116,000	$ 128,000

Note 10 - Goodwill and Intang_4

Note 10 - Goodwill and Intangible Assets - Schedule of Intangible Assets (Details) - USD ($) $ in Thousands	Dec. 31, 2023	Dec. 31, 2022
Gross Carrying Amount	$ 8,636	$ 8,636
Intangible assets, accumulated amortization	8,488	8,372
Intangible assets, net of accumulated amortization of $8,488 in 2023 and $8,372 in 2022	148	264
Patents and Licenses [Member]
Gross Carrying Amount	$ 626	626
Patents and licenses (Year)	5 years
Intangible assets, accumulated amortization	$ 540	537
Developed Technology Rights [Member]
Gross Carrying Amount	$ 7,477	7,477
Patents and licenses (Year)	10 years
Intangible assets, accumulated amortization	$ 7,471	7,387
Customer Relationships [Member]
Gross Carrying Amount	$ 272	272
Patents and licenses (Year)	7 years
Intangible assets, accumulated amortization	$ 217	189
Trade Names [Member]
Gross Carrying Amount	$ 261	261
Patents and licenses (Year)	10 years
Intangible assets, accumulated amortization	$ 260	$ 259

Note 10 - Goodwill and Intang_5

Note 10 - Goodwill and Intangible assets - Schedule of Expected Amortization Expense (Details) - USD ($) $ in Thousands	Dec. 31, 2023	Dec. 31, 2022
2024	$ 30
2025	29
2026	1
2027	1
2028 and thereafter	87
Intangible Assets, Net (Excluding Goodwill)	$ 148	$ 264

Note 11 - Accrued and Other E_3

Note 11 - Accrued and Other Expenses - Accrued Expenses (Details) - USD ($) $ in Thousands	Dec. 31, 2023	Dec. 31, 2022
Accrued salary and related expenses	$ 952	$ 725
Accrued accounts payable	1,036	1,307
Accrued professional fees	227	400
Accrued royalties and related	213	56
Other accrued expenses	20	53
Accounts Payable and Accrued Liabilities, Current	$ 2,448	$ 2,541

Note 12 - Leases (Details Textu

Note 12 - Leases (Details Textual)	1 Months Ended		12 Months Ended
Note 12 - Leases (Details Textual)	Jan. 31, 2024 USD ($) ft²	Nov. 30, 2022 USD ($)	Dec. 31, 2023 USD ($)	Dec. 31, 2022 USD ($)
Increase (Decrease) in Operating Lease Liability			$ (484,000)	$ (767,000)
Nashua, NH Office Lease [Member]
Increase (Decrease) in Operating Lease Liability		$ 600,000
Lessee, Operating Lease, Term of Contract (Month)	36 months
Area of Real Estate Property (Square Foot) \| ft²	3,000
Operating Lease, Expense	$ 46,000

Note 12 - Leases - Schedule of

Note 12 - Leases - Schedule of Components of Lease Expense (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Operating lease cost - Right of Use	$ 247	$ 209
Operating lease cost - Variable Costs	51	66
Total	298	275
Cash paid for operating cash flows from operating leases	$ 257	$ 242
Weighted-average remaining lease term of operating leases (in years) (Year)	1 year 11 months 1 day	2 years 6 months 7 days
Weighted-average discount rate for operating leases	6.79%	6.79%

Note 12 - Leases - Summary of D

Note 12 - Leases - Summary of Detained Information of Lease Liabilities (Details) - USD ($) $ in Thousands	Dec. 31, 2023	Dec. 31, 2022
2024	$ 219
2025	204
2026	85
Total lease payments	508
Less: effects of discounting	(47)
Total lease liabilities	461
Less: current portion of lease liabilities	(188)	$ (217)
Long-term lease liabilities	$ 273	$ 455

Note 13 - Stockholders' Equit_2

Note 13 - Stockholders' Equity (Details Textual) - USD ($)	2 Months Ended	3 Months Ended	12 Months Ended
Note 13 - Stockholders' Equity (Details Textual) - USD ($)	Mar. 12, 2024	Mar. 31, 2023	Dec. 31, 2023	Dec. 31, 2022	Aug. 11, 2023	Dec. 31, 2021
Proceeds from Issuance of Common Stock			$ 1,966,000	$ 0
Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount			$ 1,300,000
Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition (Year)			1 year 9 months 18 days
Share-Based Payment Arrangement, Plan Modification, Incremental Cost		$ 230,000
Stock Plans [Member]
Minimum Expected Percentage of Options Exercise Price to Fair Market Value of Common Stock				100%
The 2016 Stock Option Plan [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized (in shares)				4,700,000		2,600,000
Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant (in shares)			882,176
ESPP [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized (in shares)				950,000
Percentage of Voting Right not Eligible for ESPP				5%
Share-Based Compensation Arrangement by Share-Based Payment Award, Maximum Employee Subscription Rate				15%
Share-Based Compensation Arrangement by Share-Based Payment Award, Discount from Market Price, Offering Date				85%
Share Based Compensation Arrangement By Share Based Payment Award, Maximum Amount of Shares Per Employee				$ 25,000
Share-Based Compensation Arrangement by Share-Based Payment Award, Shares Issued in Period (in shares)				46,096
Common Stock, Capital Shares Reserved for Future Issuance (in shares)				836,824
At-the-market Sales Agreement [Member]
Common Stock, Authorized Issuance Amount					$ 25,000,000
Stock Issued During Period, Shares, New Issues (in shares)			1,057,814
Shares Issued, Price Per Share (in dollars per share)			$ 2.18
Proceeds from Issuance of Common Stock			$ 2,000,000
At-the-market Sales Agreement [Member] \| Subsequent Event [Member]
Stock Issued During Period, Shares, New Issues (in shares)	0

Note 13 - Stockholders' Equit_3

Note 13 - Stockholders' Equity - Summary of Stock Option Activity for Stock Option Plan (Details) - $ / shares	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Outstanding, shares (in shares)	2,897,663	2,610,992
Outstanding, weighted average exercise price (in dollars per share)	$ 5.57	$ 7.54
Granted, shares (in shares)		1,467,574
Granted, weighted average exercise price (in dollars per share)		$ 1.81
Exercised, shares (in shares)		(35,809)
Exercised, weighted average exercise price (in dollars per share)		$ 2.24
Forfeited, shares (in shares)		(1,145,094)
Forfeited, weighted average exercise price (in dollars per share)		$ 5.35
Outstanding, weighted average exercise price (in dollars per share)		$ 5.57	$ 7.54
Outstanding, weighted average remaining contractual term (Year)		5 years 5 months 12 days
Exercisable, shares (in shares)		1,593,935	1,906,189
Exercisable, weighted average exercise price (in dollars per share)		$ 8.08	$ 7.59

Note 13 - Stockholders' Equit_4

Note 13 - Stockholders' Equity - Stock-Based Compensation Expense Including Options and Restricted Stock by Category (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Allocated share-based compensation expense	$ 1,316	$ 1,686
Cost of Sales [Member]
Allocated share-based compensation expense	2	3
Engineering and Product Development [Member]
Allocated share-based compensation expense	222	220
Selling and Marketing Expense [Member]
Allocated share-based compensation expense	308	518
General and Administrative Expense [Member]
Allocated share-based compensation expense	$ 784	$ 945

Note 13 - Stockholders' Equit_5

Note 13 - Stockholders' Equity - Options Granted under Company's Stock Incentive Plans, Valuation Assumptions and Fair Values (Details) - $ / shares	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Average risk-free interest rate	4.36%	2.29%
Expected dividend yield	0%	0%
Expected life (in years) (Year)	2 years 10 months 24 days	3 years 6 months
Weighted average fair value (in dollars per share)	$ 0.98	$ 2.33
Minimum [Member]
Expected volatility	72.69%	66.30%
Maximum [Member]
Expected volatility	134.37%	72.04%

Note 13 - Stockholders' Equit_6

Note 13 - Stockholders' Equity - Summary of Intrinsic Values of Options (Details) - USD ($) $ / shares in Units, $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Outstanding	$ 252	$ 0
Exercisable	30	0
Exercised	$ 2	$ 0
Company’s stock price at December 31 (in dollars per share)	$ 1.77	$ 1.83

Note 14 - Income Taxes (Details

Note 14 - Income Taxes (Details Textual) - USD ($)	12 Months Ended
Note 14 - Income Taxes (Details Textual) - USD ($)	Dec. 31, 2023	Dec. 31, 2022
Deferred Tax Assets, Tax Credit Carryforwards, Total	$ 4,480,000	$ 4,427,000
Unrecognized Tax Benefits, Ending Balance	0	0
Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued, Total		0
Xoft Inc [Member]
Net Operating Loss, Limitations on Use	4,600,000
Net Operating Loss Carryforwards, Limitation on Use	656,000
Future Income Tax Liabilities Offset With Operation Loss Carryforward	4,500,000
Deferred Tax Assets, Tax Credit Carryforwards, Total	1,400,000
Domestic Tax Authority [Member]
Operating Loss Carryforwards	158,400,000
Domestic Tax Authority [Member] \| Expires Between 2024 and 2037 [Member]
Operating Loss Carryforwards	109,800,000
Domestic Tax Authority [Member] \| Indefinite Period [Member]
Operating Loss Carryforwards	48,600,000
Foreign Tax Authority [Member]
Operating Loss Carryforwards	$ 400,000
Operating Loss Carryforwards, Valuation Allowance		$ 0

Note 14 - Income Taxes - Compon

Note 14 - Income Taxes - Components of Income Tax Expense (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Federal	$ 0	$ 0
State	0	0
Foreign	0	0
Federal	1	0
State	0	0
Foreign	19	(116)
Current Income Tax Expense (Benefit)	20	(116)
Total	$ 20	$ (116)

Note 14 - Income Taxes - Summar

Note 14 - Income Taxes - Summary of Effective and the Federal Statutory Income Tax Rate (Details)	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Federal statutory rate	21%	21%
State income taxes, net of federal benefit	3.70%	2.50%
Net state impact of deferred rate change	0.20%	(1.00%)
Stock compensation expense	(4.20%)	(0.70%)
Other permanent differences	(0.60%)	(0.40%)
Change in valuation allowance	0.60%	(13.70%)
Tax credits	0.50%	2%
Accrual to tax return	0.20%	0%
Foreign Rate Differential	0%	0%
True Ups - NOL Expiration/162(m) limits	(21.80%)	(8.90%)
Effective Income Tax Rate Reconciliation, Other Reconciling Items, Percent	0.30%	0%
Effective income tax	(0.10%)	0.80%

Note 14 - Income Taxes - Deferr

Note 14 - Income Taxes - Deferred Tax Assets (Liabilities) (Details) - USD ($) $ in Thousands	Dec. 31, 2023	Dec. 31, 2022
Inventory (Section 263A)	$ 97	$ 311
Inventory reserves	15	61
Bad debt reserves	68	215
Other accruals	242	813
Deferred revenue	549	129
Accumulated depreciation/amortization	0	17
Stock options	1,127	1,108
Developed technology	205	976
Tax credits	4,480	4,427
NOL carryforward	38,263	38,234
Lease Liability	113	792
Section 174 R&D	2,425	1,749
Deferred tax assets	47,584	48,832
Valuation allowance	(47,364)	(47,930)
Right of Use Asset	(113)	(786)
Deferred Tax Liabilities, Accumulated Depreciation And Amortization	(10)	0
Goodwill tax amortization	(7)	(6)
Net deferred tax asset (liability)	$ 90	$ 110

Note 15 - Segment Reporting (De

Note 15 - Segment Reporting (Details Textual) $ in Thousands	12 Months Ended
	Dec. 31, 2023 USD ($)	Dec. 31, 2022 USD ($)	Dec. 31, 2021 USD ($)
Number of Operating Segments	1
Accounts Receivable, after Allowance for Credit Loss	$ 6,392	$ 5,769	$ 4,263
Revenue Benchmark [Member] \| Geographic Concentration Risk [Member] \| Non-US [Member]
Revenues	$ 2,300	$ 3,300
Concentration Risk, Percentage	13%	17%
Accounts Receivable, after Allowance for Credit Loss	$ 800	$ 1,500
Revenue Benchmark [Member] \| Customer Concentration Risk [Member] \| GE Healthcare [Member]
Revenues	$ 3,800	$ 4,400
Concentration Risk, Percentage	5%	22%
Revenue Benchmark [Member] \| Customer Concentration Risk [Member] \| Detection OEM Partners [Member]
Concentration Risk, Percentage	32%	29%
Revenue Benchmark [Member] \| Customer Concentration Risk [Member] \| One Major Direct Customer [Member]
Revenues	$ 1,400	$ 800
Concentration Risk, Percentage	8%	4%
Accounts Receivable [Member] \| Customer Concentration Risk [Member] \| GE Healthcare [Member]
Concentration Risk, Percentage	74%
Accounts Receivable, after Allowance for Credit Loss	$ 1,200
Accounts Receivable [Member] \| Customer Concentration Risk [Member] \| OEM Partners [Member]
Concentration Risk, Percentage	28%
Accounts Receivable, after Allowance for Credit Loss	$ 1,600
Accounts Receivable [Member] \| Customer Concentration Risk [Member] \| Largest Direct Customer [Member]
Accounts Receivable, after Allowance for Credit Loss	$ 1,500
Accounts Receivable [Member] \| Customer Concentration Risk [Member] \| Largest Detection Direct Customer [Member]
Concentration Risk, Percentage	27%
Accounts Receivable [Member] \| Customer Concentration Risk [Member] \| OEM Partners and Largest Direct Customers [Member]
Concentration Risk, Percentage	55%
Accounts Receivable, after Allowance for Credit Loss	$ 3,200

Note 15 - Segment Reporting - S

Note 15 - Segment Reporting - Summary of Concentration of Revenue by Geographic Area (Details) - Export Revenue [Member] - Geographic Concentration Risk [Member] - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Total Export Revenue	$ 2,333	$ 3,312
Europe [Member]
Percent of Export sales	10%	11%
FRANCE
Percent of Export sales	64%	52%
Other Geographic Locations [Member]
Percent of Export sales	3%	6%
BELGIUM
Percent of Export sales	13%	10%
Non-US [Member]
Percent of Export sales	13%	17%
ITALY
Percent of Export sales	6%	12%
GERMANY
Percent of Export sales	4%	8%
SWITZERLAND
Percent of Export sales	4%	9%
Other Geographic Locations in Europe [Member]
Percent of Export sales	9%	9%

Note 16 - Commitments and Con_2

Note 16 - Commitments and Contingencies (Details Textual)	12 Months Ended
Note 16 - Commitments and Contingencies (Details Textual)	Dec. 31, 2023 USD ($)
Purchase Obligation	$ 700,000
Minimum Annual Royalty Payment	250,000
Fair Value of Patent License	100,000
Royalty Obligations [Member]
Other Commitment	$ 400,000

Note 17 - Employee Benefit Pl_2

Note 17 - Employee Benefit Plan (Details Textual) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Defined Contribution Plan, Maximum Annual Contributions Per Employee, Percent		90%
Defined Contribution Plan, Employer Matching Contribution, Percent of Match		100%
Defined Contribution Plan, Employer Matching Contribution, Percent of Employees' Gross Pay		3%
Defined Contribution Plan, Employer Discretionary Contribution Amount	$ 0.4	$ 0.6